Literature DB >> 12615822

An association of IgG anti-laminin-1 autoantibodies with endometriosis in infertile patients.

Junko Inagaki1, Mayumi Sugiura-Ogasawara, Motoyoshi Nomizu, Mikiya Nakatsuka, Katsuo Ikuta, Nobuharu Suzuki, Keiko Kaihara, Kazuko Kobayashi, Tatsuji Yasuda, Yehuda Shoenfeld, Koji Aoki, Eiji Matsuura.   

Abstract

BACKGROUND: Laminin-1, a multifunctional glycoprotein of the basement membrane, is thought to be important in embryogenesis, embryonic implantation, and placentation. We recently showed that serum IgG anti-laminin-1 autoantibodies (auto-Abs) are associated with recurrent first-trimester miscarriages. The present study assessed the clinical significance of anti-laminin-1 Abs with infertility, accompanied with or without endometriosis.
METHODS: Sixty-eight infertile patients who underwent laparoscopy or laparotomy and 39 healthy non-pregnant women were tested for IgG anti-laminin-1 Abs. The association between the Abs and endometriosis was analysed. The presence of laminin-1 mRNA was detected in endometriotic lesions.
RESULTS: Twenty infertile patients were positive for anti-laminin-1 Abs. The Ab levels in those patients were significantly higher than those in healthy non-pregnant women (P = 0.0005). The presence of the Abs was significantly associated with endometriosis in those patients (P = 0.0096). The Abs recognized a particular domain, i.e., the laminin-alpha1 chain G domain. mRNA encoding laminin-alpha1, -beta1, and -gamma1 chains was expressed in 90% of endometriotic lesions.
CONCLUSIONS: IgG anti-laminin-1 Abs were significantly associated with endometriosis in infertile patients. The Abs might be clinically important in the development of autoimmune-mediated reproductive failures and the assessment of the Abs may provide a novel non-invasive diagnosis of endometriosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615822     DOI: 10.1093/humrep/deg148

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

Review 1.  Peripheral biomarkers of endometriosis: a systematic review.

Authors:  K E May; S A Conduit-Hulbert; J Villar; S Kirtley; S H Kennedy; C M Becker
Journal:  Hum Reprod Update       Date:  2010-05-12       Impact factor: 15.610

Review 2.  Blood biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Rabia Shaikh; Cindy Farquhar; Vanessa Jordan; Carola S Scheffers; Ben Willem J Mol; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-05-01

3.  Anti-laminin-1 antibodies in serum and follicular fluid of women with Hashimoto's thyroiditis undergoing in vitro fertilization.

Authors:  Domenico Caccavo; Nelly M Pellegrino; Claudia Nardelli; Silvia Vergine; Luca Leone; Alessandra Marolla; Margherita P Vacca; Raffaella Depalo
Journal:  Int J Immunopathol Pharmacol       Date:  2016-01-26       Impact factor: 3.219

Review 4.  Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies†.

Authors:  Abdelrahman AlAshqar; Lauren Reschke; Gregory W Kirschen; Mostafa A Borahay
Journal:  Biol Reprod       Date:  2021-07-02       Impact factor: 4.285

5.  The FCRL3 -169T>C polymorphism and the risk of endometriosis-related infertility in a Polish population.

Authors:  Malgorzata Szczepańska; Przemyslaw Wirstlein; Hanna Hołysz; Jana Skrzypczak; Paweł P Jagodziński
Journal:  Arch Gynecol Obstet       Date:  2013-04-04       Impact factor: 2.344

Review 6.  Potential involvement of the immune system in the development of endometriosis.

Authors:  Cleophas M Kyama; Sophie Debrock; Jason M Mwenda; Thomas M D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2003-12-02       Impact factor: 5.211

Review 7.  Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives.

Authors:  Costin Vlad Anastasiu; Marius Alexandru Moga; Andrea Elena Neculau; Andreea Bălan; Ioan Scârneciu; Roxana Maria Dragomir; Ana-Maria Dull; Liana-Maria Chicea
Journal:  Int J Mol Sci       Date:  2020-03-04       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.